We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$110B
AUM Growth
+$9.81B
Cap. Flow
+$1.34B
Cap. Flow %
1.22%
Top 10 Hldgs %
20.07%
Holding
4,881
New
700
Increased
2,284
Reduced
1,341
Closed
315

Sector Composition

Rank Sector Weight
1 Financials 9.74%
2 Technology 9.35%
3 Energy 7.63%
4 Healthcare 7.59%
5 Industrials 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEAF
3576
DELISTED
Leaf Group Ltd.
LEAF
$559K ﹤0.01%
48,883
+28,159
+136% +$303K
LDR
3577
DELISTED
Landauer Inc
LDR
$558K ﹤0.01%
10,630
-2,556
-19% -$129K
SCLN
3578
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$558K ﹤0.01%
110,700
-34,587
-24% -$166K
AIVI icon
3579
WisdomTree International AI Enhanced Value Fund
AIVI
$61.7M
$557K ﹤0.01%
11,700
+6,700
+134% +$313K
BSJD
3580
DELISTED
GUGGENGEIM BULLETSHARES 2013 HIGH YIELD CORPORATE BOND ETF
BSJD
$557K ﹤0.01%
21,814
MCS icon
3581
Marcus Corp
MCS
$894M
$556K ﹤0.01%
41,323
+21,163
+105% +$299K
COWN
3582
DELISTED
Cowen Inc. Class A Common Stock
COWN
$555K ﹤0.01%
35,462
+10,056
+40% +$154K
ICLR icon
3583
Icon
ICLR
$12.6B
$554K ﹤0.01%
13,709
-23,854
-64% -$948K
ABAX
3584
DELISTED
Abaxis Inc
ABAX
$554K ﹤0.01%
13,815
+1,997
+17% +$73.8K
EXG icon
3585
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.99B
$553K ﹤0.01%
55,274
-2,365
-4% -$23.2K
SABA
3586
Saba Capital Income & Opportunities Fund II
SABA
$220M
$553K ﹤0.01%
34,763
+27,078
+352% +$442K
PRTA icon
3587
Prothena Corp
PRTA
$425M
$552K ﹤0.01%
+20,828
New +$522K
MDXG icon
3588
MiMedx Group
MDXG
$602M
$551K ﹤0.01%
63,046
+18,626
+42% +$114K
PDFS icon
3589
PDF Solutions
PDFS
$1.93B
$550K ﹤0.01%
21,440
+849
+4% +$19.5K
CYTK icon
3590
Cytokinetics
CYTK
$10.5B
$548K ﹤0.01%
84,347
+18,770
+29% +$123K
CONE
3591
DELISTED
CyrusOne Inc Common Stock
CONE
$548K ﹤0.01%
24,572
+4,696
+24% +$95.5K
JTD
3592
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
$548K ﹤0.01%
35,009
-2,259
-6% -$33.9K
NTT
3593
DELISTED
Nippon Telegraph & Telephone
NTT
$548K ﹤0.01%
20,275
-34,168
-63% -$897K
DSGX icon
3594
Descartes Systems
DSGX
$6.44B
$547K ﹤0.01%
+40,876
New +$515K
FRED
3595
DELISTED
Fred's Inc
FRED
$547K ﹤0.01%
29,599
-29,190
-50% -$485K
MITL
3596
DELISTED
Mitel Networks Corporation
MITL
$546K ﹤0.01%
+54,090
New +$408K
TVIZ
3597
DELISTED
VelocityShares Daily 2x VIX Medium Term ETN
TVIZ
$546K ﹤0.01%
3,172
+2,000
+171% +$434K
CSFL
3598
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$545K ﹤0.01%
53,634
+8,327
+18% +$85.2K
MUB icon
3599
iShares National Muni Bond ETF
MUB
$45.1B
$544K ﹤0.01%
5,241
-1,704
-25% -$178K
PERI icon
3600
Perion Network
PERI
$375M
$543K ﹤0.01%
+14,983
New +$518K

Similar funds

Credit Suisse's Q4 2013 Portfolio in Review

As of Q4 2013, Credit Suisse held 4,881 positions worth $110B, up 9.8% from $101B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Credit Suisse's Q4 2013 filing shows 700 new, 2,284 increased, 1,341 reduced and 315 closed positions. Its largest new stake was Deutsche Bank: 9,817,335 shares worth $403M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.92B.

By sector, the portfolio is most concentrated in Financials at 9.7% of assets, up from 8.1% a quarter earlier, followed by Technology and Energy.

  • Credit Suisse's largest Q4 2013 buy was Deutsche Bank: 9,817,335 shares worth $403M.
  • Credit Suisse added most to Elevance Health in Q4 2013, an estimated $191M increase.
  • Credit Suisse's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.92B.
  • Credit Suisse fully exited NYSE EURONEXT INC in Q4 2013, selling an estimated $231M.
  • Credit Suisse's ten largest holdings make up 20% of its $110B portfolio in Q4 2013.
  • Credit Suisse opened 700 new positions and closed 315 in Q4 2013.
  • Credit Suisse's portfolio value rose 9.8% quarter-over-quarter to $110B.

Based on Credit Suisse's 13F filing for Q4 2013, filed 14 Feb 2014.